• Personal Data
  • Qualifications
  • Employment History
  • Administrative positions
  • Teaching Expertise
  • Computer Skills
  • Co-ordination of Academic Activities and Research
  • Intra-university Membership
  • Extra-university Memberships
  • Public Output
  • Workshops and Courses Attended
  • Conferences
  • Scholarship
  • Publications

Publications

1- Evidence of Clinical and Economic Benefits of Clinical Pharmacist interventions in Warfarin Anticoagulant Therapy. Bashier Osman, Ahmed Almubark, Iman H. Abdoon, Elkhansa Abelhamid, Elrashied AE, Garelnabi.

International Journal of Pharmacy. Photon 104 (2013) 374-380

2- Prophylactic ceftizoxime for elective cesarean delivery at Soba Hospital, Sudan.

Bashier Osman, Amna Abbas, Mohamed A Ahmed, Magid S Abubaker, IshagAdam. BMC Research Notes 02/2013; 6(1):57.

3-Effect of Ethanolic Leaf Extract of Moringa oleifera on Aluminum-induced Anemia in White Albino Rats. Hisham M. Osman, Mohamed E. Alshayoub, Elsiddig M. Babiker, Bashier Osman, Ali M. Elhassan. Jordan Journal of Biological Sciences. 11/2012; 5(4):255-260.

4- Cyclosporin A and tacrolimus induce renal Erk1/2 pathway via ROS-induced and metalloproteinase-dependent EGF-receptor signaling. El-Sayed Akool, Stefan Gauer, Bashier Osman, Anke Doller, Sebastian Schulz, Helmut Geiger, Josef Pfeilschifter, Wolfgang Eberhardt. Biochemical pharmacology 11/2011; 83(2):286-95.

5- Differential modulation of the cytokine-induced MMP-9/TIMP-1 protease-antiprotease system by the mTOR inhibitor rapamycin. Bashier Osman, El-Sayed Akool, Anke Doller, Roswitha Müller, Josef Pfeilschifter, Wolfgang Eberhardt.

 Biochemical pharmacology 01/2011; 81(1):134-43.

 6-Rapamycin induces the TGFbeta1/Smad signaling cascade in renal mesangial cells upstream of mTOR. Bashier Osman, Anke Doller, El-Sayed Akool, Martin Holdener, Edith Hintermann, Josef Pfeilschifter, Wolfgang Eberhardt  Cellular signalling 09/2009; 21(12):1806-17.

 

Conference Proceeding:

1- Activation of Smad-dependent Signaling Pathways by the mTOR Inhibitor Sirolimus in Rat Glomerular Mesangial Cells. Osman B., Doller A., Akool E.S., Pfeilschifter J., Eberhardt W. Naunyn-Schmiedeberg´s Arch Pharmacol (2008) 377 (Suppl 1):1-98. The 49th Annual Meeting of the German Society forExperimental and Clinical Pharmacology and Toxicology. March 11-13, 2008. Mainz, Germany.

2- The mTOR Kinase Inhibitor Rapamycin Propagates Profibrotic Cell Signaling Cascades in Rat Renal Mesangial Cells. Osman B., Doller A., Akool E.S., Hintermann E., Pfeilschifter J., Eberhardt W. Naunyn-Schmiedeberg´s Arch Pharmacol (2009) 379 (Suppl 1):1-100.The 50th Annual Meeting of the GermanSociety for Experimental and Clinical Pharmacology and Toxicology. March 10-12, 2009. Mainz, Germany.

3- Bioequivalence study of seven amoxicillin capsule brands currently registered in Sudan. Osman B, Idris B. Eltayeb, H. A. Elsheikh, Iman H. Abdoon. JBioequiv Availab, Volume 4 Issue 3 – 77. 3rd World Congress on Bioavailability &Bioequivalence,, Marriott Hotel & Convention Centre, Hyderabad, India.; 03/2012.

4- Effect of Chloroquine On The Pharmacokinetics Of Ivermectin FollowingOral Administration In Healthy Volunteers. Hatim A.Elsheikh, Iman H.Abdoon, Idris B. Eltayeb, Bashier I. Osman. J Clin Pharmcol 2011;1326-1369. The 40th Annual Meeting of the American College of ClinicalPharmacology, Chicago, Illinois; 09/2011.